EGFR and lung carcinoma: In lung cancer cell lines (PC-9G and H1975), presenting a resistance to EGFR tyrosine kinase inhibitors due to the mutation T790M, SAHA restored the sensitivity to these inhibitors by promoting both apoptosis and autophagy-linked cell death [90].